TITLE

New drug to prevent NSAID-related ulcers

AUTHOR(S)
Liss, Gary M.
PUB. DATE
October 1996
SOURCE
CMAJ: Canadian Medical Association Journal;10/15/1996, Vol. 155 Issue 8, p1043
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35493996

 

Related Articles

  • An update on nonsteroidal anti-inflammatory drugs and cardiovascular risk. Part 1. van Schoor, Jacky // South African Pharmaceutical Journal;2014, Vol. 81 Issue 1, p19 

    Guidelines for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications have recently been made available through an initiative designed in collaboration with leading specialists in South Africa. For the purposes of...

  • An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk. Part 2. van Schoor, Jacky // South African Pharmaceutical Journal;2014, Vol. 81 Issue 2, p10 

    Recommendations for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications were recently made available through an initiative designed in collaboration with leading specialists in South Africa. The prevention of CV...

  • An update on nonsteroidal anti-inflammatory drugs and cardiovascular risk. Part 1. van Schoor, Jacky // South African Pharmaceutical Journal;2014, Vol. 81 Issue 1, p19 

    Guidelines for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications have recently been made available through an initiative designed in collaboration with leading specialists in South Africa. For the purposes of...

  • Peptic ulcers in the elderly: Unique features and management. Freston, M.S.; Freston, J.W. // Geriatrics;Jan1990, Vol. 45 Issue 1, p39 

    Contrary to the general trend, peptic ulcers are on the rise in the elderly in terms of frequency, complications, and mortality, possibly due to the use of and complications from nonsteroidal anti-inflammatory drugs (NSAIDs). Unfortunately, the infrequency of abdominal pain and the frequent...

  • Acid Suppression as Treatment for NSAID-Related Peptic Ulcers. Howden, Colin W.; Holt, Stephen // American Journal of Gastroenterology;Dec1991, Vol. 86 Issue 12, p1720 

    Examines the effectiveness of acid suppression as treatment for nonsteriodal anti-inflammatory drugs (NSAID)-related peptic ulcers. Agent that produced the greatest degree of suppression of acidity and the highest ulcer healing rates in man; Information on the optical treatment for patients...

  • Helicobacter Pylori-Associated Peptic Ulcer Disease in Older Patients: Current Management Strategies. Pilotto, A. // Drugs & Aging;2001, Vol. 18 Issue 7, p487 

    The incidence of peptic ulcer and its severe complications, i.e. bleeding or perforation, is increasing in elderly patients worldwide. The prevalence of Helicobacter pylori infection in patients with peptic ulcer aged over 65 years has been reported to range from 58 to 78%. However, in elderly...

  • Management of NSAID-Induced Gastrointestinal Toxicity: Focus on Proton Pump Inhibitors. Lazzaroni, Marco; Porro, Gabriele Bianchi // Drugs;2009, Vol. 69 Issue 1, p51 

    The association between NSAIDs and the presence of upper gastrointestinal (GI) complications is well established. Evidence that acid aggravates NSAID-induced injury provides a rationale for minimizing such damage by acid suppression. Proton pump inhibitors (PPIs) appear to be very effective in...

  • Direct Medical Costs of Serious Gastrointestinal Ulcers among Users of NSAIDs. Vonkeman, Harald E.; Klok, Rogier M.; Postma, Maarten J.; Brouwers, Jacobus R. B. J.; Van De Laar, Mart A. F. J. // Drugs & Aging;2007, Vol. 24 Issue 8, p681 

    Background: The occurrence and prevention of gastrointestinal ulcers during use of NSAIDs has become a major healthcare issue. Objective: To determine the direct medical costs of serious NSAID-related ulcer complications. Method: An observational cost-of-illness study was conducted in a large...

  • Osteoarthritis therapy with a built-in PPI.  // Clinical Advisor;Oct2010, Vol. 13 Issue 10, p24 

    The article offers information about the drug Vimovo, a nonsteroidal anti-inflamatory drug (NSAID) and a proton pump inhibitor (PPI), from AstraZeneca. It notes that the drug is indicated for osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. In addition, it reduces the risk of...

  • New drugs you're giving now. Rodman, Morton J. // RN;Mar90, Vol. 53 Issue 3, p67 

    Presents information on several new drugs available as of March 1990. Effects of the drugs; How the drugs work; Drug designed to prevent drug-induced ulcers; Re-approval of Bupropion, a drug for depression.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics